To view this email as a web page, click here.

May 13, 2019 Baricitinib and Cardiovascular Events Baricitinib treatment does not increase the risk for cardiovascular problems in patients with rheumatoid arthritis, according to new research. Read more   Tofacitinib and Cardiovascular Events Rheumatoid arthritis patients taking tofacitinib could face some increased risks for significant cardiovascular events, depending upon their underlying characteristics, according to the results of a new study. Read more   MORE FROM RHEUMATOLOGY NETWORK   The High Impact of Disease vs Financial Well-Being Biologic DMARD Tapering Gets the Green Light in RA Higher Risk of Cancer Recurrence Unlikely With TNFi Therapy in RA

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.

This email was sent by: MultiMedia Healthcare 535 Connecticut Avenue, Suite 300 Norwalk, CT, 06854, USA NEWSLETTER Privacy Statement Terms of Service Unsubscribe Add/Remove Newsletters Contact Us CONNECT